Neurology, Swiss Paraplegic Centre, Nottwil, Switzerland.
Swiss Paraplegic Research, Nottwil, Switzerland.
Spinal Cord Ser Cases. 2024 Jul 31;10(1):53. doi: 10.1038/s41394-024-00667-w.
A feasibility study.
Chronic neuropathic pain is a prevalent comorbidity in patients with spinal cord injury (SCI), and current medical treatments remain unsatisfactory. New developments as virtual walking are emerging which has been established and further developed at our centre. This study aims to investigate the feasibility of our virtual walking setup in a small group of SCI patients.
The study was conducted at the Swiss Paraplegic Centre in Nottwil, Switzerland.
Four patients aged 22 to 60 years were observed during and after therapy. Three had complete paraplegia (levels Th4-Th8) with neuropathic at- and below-level pain, while one had incomplete paraplegia (Th10) with at-level pain. The primary outcome measured was satisfaction with acceptance of and adherence to virtual walking therapy, alongside suggestions for therapy improvements. Additionally, patients kept a pain diary and pain drawings to measure the extent of pain distribution and intensity before and after therapy. Therapy schedules included either two sessions per week for five weeks or five sessions per week for two weeks.
There was a sound satisfaction and good acceptance amongst participants. Support, duration, and number of sessions were perceived well and acceptable. Pain as a secondary outcome did not change during or after therapy in all but one patient which improved in pain intensity, pain quality as well as pain distribution.
Results suggest that our virtual walking setting is a feasible tool that should be further studied in patients with SCI-related chronic neuropathic pain.
一项可行性研究。
慢性神经性疼痛是脊髓损伤(SCI)患者常见的合并症,目前的医学治疗效果仍不尽如人意。新的发展,如虚拟行走,已经在我们中心得到建立和进一步发展。本研究旨在调查我们的虚拟行走设备在一小部分 SCI 患者中的可行性。
瑞士诺特维尔的瑞士截瘫中心。
在治疗期间和治疗后观察了 4 名年龄在 22 至 60 岁的患者。其中 3 名完全截瘫(Th4-Th8 水平),伴有神经性上下水平疼痛,而 1 名不完全截瘫(Th10 水平),伴有水平疼痛。主要的测量结果是对虚拟行走治疗的接受程度和坚持程度的满意度,以及对治疗改进的建议。此外,患者记录疼痛日记和疼痛图,以测量治疗前后疼痛分布和强度的程度。治疗方案包括每周两次,持续五周,或每周五次,持续两周。
参与者的满意度和接受度都很高。支持、治疗时长和治疗次数都被认为很好且可以接受。除了一名患者的疼痛强度在治疗期间或治疗后没有变化外,作为次要结果的疼痛在所有患者中都没有变化,该患者的疼痛强度、疼痛质量和疼痛分布都有所改善。
结果表明,我们的虚拟行走设备是一种可行的工具,应该在 SCI 相关慢性神经性疼痛患者中进一步研究。